Abstract:Background: To evaluate the prognostic value of the proposed 8th Edition of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system for nasopharyngeal carcinoma (NPC) patients without cervical lymph node metastasis in comparison with the AJCC/ UICC 7th edition. Methods: This is a retrospective study of 382 newly diagnosed non-metastatic NPC patients without cervical Lymph node metastasis who were treated with intensity-modulated radiotherapy (IMRT). All received elective neck irradiation to levels II, III, VA. Univariate and multivariate analyses were applied to evaluate the prognostic values between adjacent stage categories of the AJCC/ UICC 7th edition and the proposed 8th edition, including overall survival (OS), local relapse-free survival (LRFS), regional relapse-free survival (RRFS), distant metastasis-free survival (DMFS), and disease–free survival (DFS). The Akaike information criterion (AIC) and Harrell’s concordance index (c-index) were applied to compare the two prognostic systems with different numbers of stages. Results: The median follow-up time was 61.1 months, with a range from 1 months to 91 months. The 5-year OS, LRFS, RFFS, DMFS and DFS were 86.9%, 96.7%, 99.1%, 93.3% and 82.6%, respectively. For LRFS and DMFS, the proposed eighth editions had superior prognostic value to the AJCC/ UICC 7th edition (P = 0.032 vs. P = 0.086 and P = 0.013 vs. P = 0.112). The 5-year OS and DFS were found to be significant both by the seventh and the proposed 8th editions. The difference between T1 and T3, T1 and T4, T2 and T3 and T2 and T4 by the proposed eighth edition were found to be significant (P = 0.042, P = 0.041, P = 0.000, and P = 0.000), however, there was no significant difference between T1 and T3, T2 and T3 by the seventh edition (P = 0.204, and P = 0.215). In addition, the difference between T1, T2, T3 with T4 were found to be significant in DFS (P = 0.000, P = 0.000, P = 0.037) and there was no significant difference between T1 and T3 (P = 0.162) by the seventh edition and there was significantly different between T2 and T4 (P = 0.026) by the proposed 8th editions. Multivariate analysis demonstrated that age, T stage of the proposed 8th editions and chemotherapy were independent prognostic factors for OS, LRFS, DMFS and DFS. The AIC value was smaller for the 8th edition compared to the 7th edition staging system. The C-index value was larger for the 8th edition compared to the 7th edition staging system. Conclusions: IMRT with elective neck irradiation provides excellent local-regional control for NPC patients without cervical lymph node metastasis. The proposed eighth editions had superior prognostic value to the AJCC/ UICC 7th edition for LRFS and DMFS and lead a better distinction between adjacent T stages of nasopharyngeal carcinoma patients for OS and DFS. Overall, the proposed 8th UICC T classification seems to be superior to the 7th UICC T classification for nasopharyngeal carcinoma patients without cervical lymph node metastasis. Legal entity responsible for the study: Fudan University Shanghai Cancer Center. Funding: Has not received any funding. Disclosure: The author has declared no conflicts of interest.

Comparison of the 7 th and proposed 8 th editions of the AJCC/UICC TNM staging system for non-small cell lung cancer undergoing radical surgery

Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non–small-cell Lung Cancer

Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis

Comparison of the 7th and 8th edition of American Joint Committee on Cancer (AJCC) staging systems for breast cancer patients: a Surveillance, Epidemiology and End Results (SEER) Analysis.

Comparison of the 7th and 8th Edition of the UICC/AJCC TNM Staging System in Primary Resected Squamous Cell Carcinomas of the Lung-A Single Center Analysis of 354 Cases.

A Comparison the 7th and 8th Edition AJCCTNM Staging Systems for Predicting Disease Free Survival Time after Surgery in Primary Liver Cancer Patients

Evaluation of the 7th Edition of the TNM Classification for Lung Cancer at a Single Institution.

Comparison Between the 7th and the Proposed 8th Editions of the UICC Staging System for Nasopharyngeal Carcinoma Patients Without Cervical Lymph Node Metastasis: A Retrospective Analysis

Evaluation of the Eighth Edition of the American Joint Committee on Cancer TNM Staging System for Gastric Cancer: an Analysis of 7371 Patients in the SEER Database

Validation of the stage groupings in the 8th edition of the TNM classification for lung cancer.

Validation of the Postneoadjuvant Therapy Pathological Stage of the American Joint Committee on Cancer (AJCC) 8th Edition for Predicting Outcomes of Esophageal Squamous Cell Carcinoma (ESCC) Patients Receiving Neoadjuvant Chemoradiotherapy (CRT) Followed by Esophagectomy.

Superiority of the 8th Edition of the TNM Staging System for Predicting Overall Survival in Gastric Cancer: Comparative Analysis of the 7th and 8th Editions in a Monoinstitutional Cohort.

The Revision of 8th Edition TNM Stage Criteria is More Accurate in Prediction Postoperative Survival for SCLC Patients

Comparison of the TNM9th and 8th editions for localized and locally advanced anal squamous cell carcinoma treated nonsurgically and proposal of a new stage grouping system

Validation of the 9th edition of the TNM staging system for non-small cell lung cancer with lobectomy in stage IA–IIIA

The 8th Edition of the American Joint Committee on Cancer Tumor-Node-metastasis Staging System for Gastric Cancer is Superior to the 7th Edition: Results from a Chinese Mono-Institutional Study of 1663 Patients.

Is the 8th Edition of the AJCC TNM Staging System Sufficiently Reasonable for All Patients with Noncardia Gastric Cancer? A 12,549-Patient International Database Study

Should Patients with Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy? A Comparison of Survival Between the 8th and 7th Editions of the AJCC TNM Staging System for Stage IB Patients.

Comparison of the 7th and 6th edition AJCC TNM staging systems for gastric cancer: analysis of prognosis in a retrospective review of 918 patients at a single institution in China

Comparison of Prognostic Performance of 8th and 7th Edition of AJCC Staging System for Patients With Gallbladder Cancer Undergoing Curative Intent Surgery

A Comparison of the Seventh and Eighth Editions of the AJCC Staging Systems to Predict Recurrence in Papillary Thyroid Microcarcinoma